Latest Insights on DB

Boeing is flying high again after the FAA cleared the 737 Max. Are you ready to jump off the deck and shove it into overdrive? Boeing’s Back, Apple Pied; Nikola’s Cummins and Goin’s
by Joseph Hargett November 18, 2020 Great Stuff
Take These Broken Wings The Boeing Company (NYSE: ) is learning to fly again, learning to live so free! So, Great Ones, are you ready to jump off the deck and shove it into overdrive? Mr. Mister into Kenny Loggins? Bah. Give me Ozzy! Wait for it… BA stock is flying high again after the […]
Wall Street's vaccine rally was a nice diversion, but it’s time to face facts. We still have a long walk down that road to recovery. Retail’s Reality, Tesla’s 500 and Bezos’ Benzos
by Joseph Hargett November 17, 2020 Great Stuff
Back to Life, Back to Reality I’m rolling with a little late ‘80s hip-pop today. I know that’s not everyone’s cup of tea, but this ‘89 Soul II Soul classic seemed rather appropriate given this morning’s October retail sales data: Back to life, back to the present time, back from a fantasy. The vaccine rally […]
Can you be too cool for the vaccine race? As it turns out, yes you can! With Moderna’s vaccine coming in hot, Pfizer just got one-upped. Pfizer Pforfeit; A Nio Dealio; Uber’s Hail Mary
by Joseph Hargett November 16, 2020 Great Stuff
Born to Run In the day, we sweat it out on Wall Street. It’s a runaway American dream. At night, we’re locked in mansions of glory, no more suicide machines. But all that might be about to change… Sprung from Phase 3 on highway nine, Moderna’s new injection is stepping out over the line. (Woah!) […]
If everything goes as planned, the federal government has agreed to purchase up to 600 million doses of the COVID-19 vaccine by the end of 2021. Poll: Would You Take a COVID-19 Vaccine? If everything goes as planned, the federal government has agreed to purchase up to 600 million doses of the COVID-19 vaccine by the end of 2021.
The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it. COVID-19 Vaccine Firm Soars 650% — Huge Opportunities Ahead The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

Share This